233 filings
Page 5 of 12
424B5
txo9d18
29 Oct 20
Prospectus supplement for primary offering
5:25pm
424B5
o1pu44
28 Oct 20
Prospectus supplement for primary offering
5:29pm
424B5
jlzn1r4a93m yp
28 Oct 20
Prospectus supplement for primary offering
4:32pm
8-K
yydtv6k
9 Sep 20
Forte Biosciences, Inc. Announces Full Publication of Phase 1/2 Data In Science Translational Medicine
4:06pm
424B5
yr9vhaliom 94m2vwc9
4 Sep 20
Prospectus supplement for primary offering
4:51pm
8-K
qe6wyw
4 Sep 20
Audited Financial Statements
4:31pm
S-8
lpfjtf614f09fnjwo1d
11 Aug 20
Registration of securities for employees
5:19pm
8-K
1rztomg8vd0kt57jlzj6
10 Aug 20
Forte Biosciences, Inc. Announces Second Quarter 2020 Results and Provides General Business Update
4:04pm
8-K/A
t74om
10 Aug 20
Financial Statements and Exhibits
4:02pm
8-K
37nvorp
21 Jul 20
Changes in Registrant's Certifying Accountant
4:34pm
8-K
xi9vb
26 Jun 20
Regulation FD Disclosure
5:09pm
8-K
40g00w c0vr3
15 Jun 20
Forte Biosciences, Inc. Announces Closing of Merger with Tocagen
5:21pm
8-K
uim6on4om4aifqt3dpbl
12 Jun 20
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
6qabee0uzkvjc
8 Jun 20
Other Events
5:25pm
DEFA14A
ldgbjdwrzrrwh
28 May 20
Additional proxy soliciting materials
4:57pm
EFFECT
yqwbuv jsq
14 May 20
Notice of effectiveness
12:15am
424B3
gsasl
14 May 20
Prospectus supplement
12:00am
CORRESP
t77k7yxqklypfvc4g
13 May 20
Correspondence with SEC
12:00am